Cargando…
Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets
BACKGROUND: The Human Epidermal Growth Factor Receptor (EGFR/HER1) can be activated by several ligands including Transforming Growth Factor alpha (TGF-α) and Epidermal Growth Factor (EGF). Following ligand binding, EGFR heterodimerizes with other HER family members, such as HER2 (human epidermal gro...
Autores principales: | Nava, Miguel, Dutta, Pranabananda, Zemke, Nathan R., Farias-Eisner, Robin, Vadgama, Jaydutt V., Wu, Yanyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368760/ https://www.ncbi.nlm.nih.gov/pubmed/30736768 http://dx.doi.org/10.1186/s12920-019-0477-8 |
Ejemplares similares
-
Utilization of NGS technologies to investigate transcriptomic and epigenomic mechanisms in trastuzumab resistance
por: Nava, Miguel, et al.
Publicado: (2019) -
Fixated on fixation: using ChIP to interrogate the dynamics of chromatin interactions
por: Keren, Leeat, et al.
Publicado: (2013) -
Genetic variants in African-American and Hispanic patients with breast cancer
por: Dutta, Pranabananda, et al.
Publicado: (2022) -
A ChIP on the shoulder? Chromatin immunoprecipitation and validation strategies for ChIP antibodies
por: Wardle, Fiona C., et al.
Publicado: (2015) -
MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis
por: Dutta, Pranabananda, et al.
Publicado: (2018)